ResMed Inc. vs. Beyond Air, Inc. Common Stock
ResMed Inc. (RMD) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| RMD | XAIR | |
|---|---|---|
| Market Cap | $34.67 billion | $4.41 million |
| Revenue (TTM) | $5.65 billion | $7.69 million |
| Net Income (TTM) | $1.52 billion | $-34,410,000 |
RMD leads on 3 of 3 size & scale factors.
Valuation
| RMD | XAIR | |
|---|---|---|
| P/E Ratio | 23.04 | — |
| Price / Book | 5.26 | 1.55 |
| Price / Sales | 6.13 | 0.57 |
XAIR leads on 2 of 2 valuation factors.
Profitability
| RMD | XAIR | |
|---|---|---|
| Net Margin | 26.94% | -447.64% |
| Return on Equity | 23.13% | -1212.05% |
RMD leads on 2 of 2 profitability factors.
Dividend
| RMD | XAIR | |
|---|---|---|
| Dividend Yield | 1.10% | — |
| Payout Ratio | 25.31 | — |
RMD and XAIR split the dividend factors evenly.
Risk & Sentiment
| RMD | XAIR | |
|---|---|---|
| Short Interest | 4.04% | 5.73% |
RMD leads on 1 of 1 risk & sentiment factors.
Dig deeper: RMD overview, RMD financials, XAIR overview, XAIR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.